An Exploratory Study of Perioperative Venous Access in Obese Patients

Launched by SIR RUN RUN SHAW HOSPITAL · Sep 4, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring how different types of IV (intravenous) catheters, specifically long peripheral catheters and midline catheters, can be used safely and effectively in obese patients during and after their surgeries. The goal is to find the best way to provide IV access for these patients to reduce complications related to the catheters.

To be eligible for this study, participants need to be obese (with a body mass index or BMI of 30 or higher) and scheduled for surgery that requires a hospital stay of no more than two weeks. They should also be awake and able to communicate clearly. However, patients who might need certain medications through a different type of IV line or already have a central line in place won't be able to join the study. While the trial is not yet recruiting participants, it aims to gather important information that could help improve surgical care for obese patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Obese patients (BMI ≥ 30kg/m2) who are to undergo surgery.
• • Expected length of hospitalisation within 2 weeks.
• • Conscious and able to communicate normally.
• Exclusion Criteria:
• • It is expected that perioperative medications will need to be infused via a central venous catheter (e.g. total parenteral nutrition TPN);
• • Patients with an indwelling central venous catheter on admission